137 related articles for article (PubMed ID: 2690044)
1. Lack of effect of spironolactone on hair shaft diameter in hirsute females.
McLellan AR; Rentoul J; MacKie R; McInnes GT
Postgrad Med J; 1989 Jul; 65(765):459-62. PubMed ID: 2690044
[TBL] [Abstract][Full Text] [Related]
2. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
3. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.
Lobo RA; Shoupe D; Serafini P; Brinton D; Horton R
Fertil Steril; 1985 Feb; 43(2):200-5. PubMed ID: 3967781
[TBL] [Abstract][Full Text] [Related]
4. The effect of spironolactone on hirsutism and female androgen metabolism.
Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and clinical effects of spironolactone in female hyperandrogenism.
Siegberg R; Ylöstalo P; Laatikainen T; Pelkonen R; Stenman UH
Arch Gynecol; 1987; 240(2):67-73. PubMed ID: 3566358
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic approach to the hirsute patient.
Boisselle A; Tremblay RR
Fertil Steril; 1979 Sep; 32(3):276-9. PubMed ID: 488407
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
Barth JH; Cherry CA; Wojnarowska F; Dawber RP
J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone in the treatment of hirsutism.
Chapman MG; Katz M; Dowsett M; Hague W; Jeffcoate SL; Dewhurst CJ
Acta Obstet Gynecol Scand; 1986; 65(4):349-50. PubMed ID: 3739647
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone in the treatment of hirsutism.
Anttila L; Ruutiainen K; Erkkola R
Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
[TBL] [Abstract][Full Text] [Related]
13. Use of spironolactone in treatment of hirsutism.
Cumming DC
Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
[TBL] [Abstract][Full Text] [Related]
14. Low-dose spironolactone in the treatment of female hirsutism.
Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
[TBL] [Abstract][Full Text] [Related]
15. A novel use of spironolactone: treatment of hirsutism.
Shapiro G; Evron S
J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Lee O; Farquhar C; Toomath R; Jepson R
Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
[TBL] [Abstract][Full Text] [Related]
17. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
18. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Negri C; Tosi F; Dorizzi R; Fortunato A; Spiazzi GG; Muggeo M; Castello R; Moghetti P
J Clin Endocrinol Metab; 2000 Jan; 85(1):81-4. PubMed ID: 10634368
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].
Devoto E; Aravena L; Ríos R
Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
